A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma

Clinical trial NCT04187352 · COMPLETED

Trial details

NCT number: NCT04187352
Sponsor: CStone Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Start date: 2019-12-19
Primary completion: 2022-10-07
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.